During the past decade, Centre Hospitalier de Saint-Quentin conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 9 clinical trials were completed, i.e. on average, 17% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 4 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier de Saint-Quentin" #1 sponsor was "Intergroupe Francophone de Cancerologie Thoracique" with 17 trials, followed by "Hoffmann-La Roche" with 13 trials sponsored, "Centre Hospitalier Universitaire, Amiens" with 9 trials sponsored, "Intergroupe Francophone du Myelome" with 4 trials sponsored and "The Lymphoma Academic Research Organisation" with 4 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier de Saint-Quentin" #1 collaborator was "Amgen" with 3 trials as a collaborator, "Ministry of Health, France" with 3 trials as a collaborator, "Groupe Francais De Pneumo-Cancerologie" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator and "Merck Sharp & Dohme LLC" with 2 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier de Saint-Quentin" are "Multiple Myeloma" (8 trials), "Carcinoma, Non-Small-Cell Lung" (6 trials), "Non-Small Cell Lung Cancer" (4 trials), "Small Cell Lung Cancer" (4 trials) and "Non Small Cell Lung Cancer" (3 trials). Many other conditions were trialed in "Centre Hospitalier de Saint-Quentin" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier de Saint-Quentin" are "Drug" (60 trials), "Other" (12 trials), "Biological" (7 trials), "Device" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (7 trials), "Pemetrexed" (7 trials), "Atezolizumab" (5 trials), "Gemcitabine" (5 trials) and "Pembrolizumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier de Saint-Quentin" are 85 trials for "All" genders, 4 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Centre Hospitalier de Saint-Quentin". 1 are not yet recruiting, 17 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 44 completed trials in Centre Hospitalier de Saint-Quentin, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier de Saint-Quentin, 1 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 11 trials that are defined as “Not Applicable".